Rubin Lewis J
University of California, San Diego School of Medicine, San Diego, CA, USA,
Handb Exp Pharmacol. 2013;218:551-5. doi: 10.1007/978-3-642-38664-0_22.
Despite major advances in our understanding of the pathobiology of pulmonary vasculopathy and in the treatment of pulmonary vascular disease, pulmonary hypertension remains a severe condition that frequently progresses to right heart failure and death. This chapter will review several novel approaches to treatment, based on recent observations in both patients and experimental models, that may lead to new and more effective treatment approaches to pulmonary hypertension in the future.
尽管我们对肺血管病病理生物学的理解以及对肺血管疾病的治疗取得了重大进展,但肺动脉高压仍然是一种严重的疾病,常常进展为右心衰竭和死亡。本章将基于近期在患者和实验模型中的观察结果,综述几种新的治疗方法,这些方法可能会在未来带来新的、更有效的肺动脉高压治疗途径。